# Implicity: Observational study in Cardiovascular Diseases (CVD), Cardiac Implantable Electronic Device (CIED) (100000 participants)

**Score:** 50/100

| Field | Value |
|---|---|
| Sponsor | Implicity |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | EValuation of prognostIc and Cost reDuction by tElemonitoring iN CIEDs Usual carE: an Updated Analysis Using 2019-2023 Data |
| NCT ID | NCT07881250 |
| Phase | Observational |
| Status | active not recruiting |
| Conditions | Cardiovascular Diseases (CVD); Cardiac Implantable Electronic Device (CIED) |
| Intervention types | other, device |
| Target enrollment | 100000 |
| Site countries | France |
| Posted | 2026-10-19 |
| Planned start | 2026-10-07 |
| Event | Newly registered study |
| Event date | 2026-10-19 |

## Why this score
- Industry sponsor (buys outsourced services).
- 100000 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07881250). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.